{
    "2021-11-30": [
        [
            {
                "time": "2023-10-15",
                "original_text": "Biotech Penny Stocks to Buy Now",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Penny Stocks",
                        "Buy Now"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "AbbVie Submits Application for Risankizumab (SKYRIZI®) in Moderate to Severe Crohn's Disease to European Medicines Agency (EMA)",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Risankizumab",
                        "SKYRIZI®",
                        "Crohn's Disease",
                        "EMA"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}